Diffuse Parenchymal Lung disease Interstitial lung disease
Conditions
Interventions
None listed
Sponsors
Academisch Medisch Centrum
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Interstitial lung disease patients with an indication for lung tissue sampling
Exclusion criteria
Exclusion criteria: * Inability and willingness to provide informed consent * Inability to comply with study protocol * Use of clopidogrel, or other new anti-platelet therapy, or anticoagulant drugs that cannot be stopped temporarily * Thrombocytopenia 1.3 * Pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| -To describe visual qualitative characteristics of CLE, OCT and HHGM images of the alveolar compartment and the airway wall in ILD -To obtain quantitative measurements of ILD by analysis of the CLE, OCT and HHGM imaging of the alveolar compartment (size of the alveoli (um), thickness of the alveolar septum) -To compare the CLE, OCT and HHGM images with pathology results -To identify specific structures and cells (i.e. collagen fibres, elastin, inflammatory cells) on HHGM images of lung tissue -To identify specific structures and cells (i.e. collagen fibres, elastin, inflammatory cells) on HHGM images in ILD | — |
Secondary
| Measure | Time frame |
|---|---|
| -To create an image atlas with pOCT, pCLE and HHGM images of the airway wall and alveolar compartment in ILD -Assessing procedure-related adverse events of pCLE and pOCT -Assessing technical feasibility of pCLE, pOCT and HHGM -To assess the timeframe that is necessary for adequate HHGM images of lung tissue in ILD | — |
Countries
Netherlands
Outcome results
None listed